AAN 2021: Investigational Vidofludimus Calcium Slows Evidence of Progression on Imaging in Relapsing–Remitting Multiple Sclerosis
Favorable efficacy and safety data have prompted a phase III trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.